Cost-Minimization Analysis Favours Intravenous Ferric Carboxymaltose over Ferric Sucrose for the Ambulatory Treatment of Severe Iron Deficiency

OBJECTIVE: Intravenous iron is widely used to treat iron deficiency in day-care units. Ferric carboxymaltose (FCM) allows administration of larger iron doses than iron sucrose (IS) in each infusion (1000 mg vs. 200 mg). As FCM reduces the number of infusions required but is more expensive, we perfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Calvet, Xavier, Ruíz, Miquel Àngel, Dosal, Angelina, Moreno, Laura, López, Maria, Figuerola, Ariadna, Suarez, David, Miquel, Mireia, Villoria, Albert, Gené, Emili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448662/
https://www.ncbi.nlm.nih.gov/pubmed/23029129
http://dx.doi.org/10.1371/journal.pone.0045604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448662/
https://www.ncbi.nlm.nih.gov/pubmed/23029129
http://dx.doi.org/10.1371/journal.pone.0045604

Ejemplares similares